2,2-dimethylvaleric acid structure
|
Common Name | 2,2-dimethylvaleric acid | ||
---|---|---|---|---|
CAS Number | 1185-39-3 | Molecular Weight | 130.18500 | |
Density | 0.918 g/mL at 20 °C(lit.) | Boiling Point | 200-205°C | |
Molecular Formula | C7H14O2 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 200-205°C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 2,2-Dimethylpentanoic acid |
---|---|
Synonym | More Synonyms |
Density | 0.918 g/mL at 20 °C(lit.) |
---|---|
Boiling Point | 200-205°C |
Molecular Formula | C7H14O2 |
Molecular Weight | 130.18500 |
Flash Point | 200-205°C |
Exact Mass | 130.09900 |
PSA | 37.30000 |
LogP | 1.89730 |
Vapour Pressure | 0.0889mmHg at 25°C |
Index of Refraction | n20/D 1.422 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C: Corrosive; |
Risk Phrases | R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 3265 8/PG 3 |
WGK Germany | 3 |
RTECS | YV6487500 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2915900090 |
Precursor 10 | |
---|---|
DownStream 3 | |
HS Code | 2915900090 |
---|---|
Summary | 2915900090 other saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:5.5% General tariff:30.0% |
Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 862(1-2) , 168-74, (2008) 2,2-Dimethylbutyrate (DMB) is a potential treatment for thalassemia and hemoglobinopathies. To facilitate pharmacokinetic evaluation of DMB, we developed an LC-MS assay and quantitated DMB in plasma o... |
|
Effects of branched-chain fatty acids on GABA-degradation and behavior: further evidence for a role of GABA in quasi-morphine abstinence behavior.
Pharmacol. Biochem. Behav. 13(6) , 843-9, (1980) An increase in GABA-ergic activity has been implicated in the initiation of quasi-morphine abstinence behavior by di-n-propylacetate (DPA). Two structural analogues of DPA, namely, the branched-chain-... |
|
Effects of the lipid regulator drug gemfibrozil: A toxicological and behavioral perspective.
Aquat. Toxicol. 170 , 355-64, (2016) Pharmaceuticals are emerging contaminants as their worldwide consumption increases. Fibrates such as gemfibrozil (GEM) are used in human medicine to reduce blood concentrations of cholesterol and tria... |
2,2-Dimethylpentanoic Acid |
2,2-Dimethylvaleric Acid |
EINECS 214-682-4 |
MFCD00021686 |